The Effect of Covid-19 on the Respiratory System

Article Sidebar

PDF
Published: Jul 27, 2023
DOI: https://doi.org/10.47191/ijmscrs/v3-i7-35
Keywords:
COVID-19. SARS-CoV-2 . FDA . RT-PCR

Main Article Content

Gufran Kadhim Abdulkareem
Southern Technical University. Basra Technical Institute,Technique of pharmacy department, Basra, Iraq.
Estabraq AbduIkareem Qahtan
Southern Technical University. Basra Technical Institute,Technique of pharmacy department, Basra, Iraq.

Abstract

This study aims to assess the risk factors associated with COVID-19 patients at the General Basrah Hospital from June to October 2020. Since COVID-19 is related to acute respiratory distress syndrome, very few interstitial mononuclear inflammatory infiltrates were detected within the heart tissue samples during the research period [3]. The results of the study demonstrate that COVID-19 infections were more common in patients with cardiovascular diseases and acute respiratory. People aged >51 years showed a higher COVID-19 infection rate.


Conclusions: The study demonstrates that COVID-19 infection rates were higher in patients with cardiovascular and acute respiratory diseases. Covid 19 posed a similar risk to males and women.

Article Details

How to Cite
Gufran Kadhim Abdulkareem, & Estabraq AbduIkareem Qahtan. (2023). The Effect of Covid-19 on the Respiratory System. International Journal of Medical Science and Clinical Research Studies, 3(07), 1423–1425. https://doi.org/10.47191/ijmscrs/v3-i7-35
Issue
Vol. 3 No. 07 (2023): Volume 03 Issue 07 July 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Peiris J, Chu C, Cheng V, Chan K, Hung I, Poon L, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767–72.

II. 2-Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.

III. A report of the Surgeon General. The health consequences of smoking: 50 years of progress.

IV. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091-

V. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

VI. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727–33.

VII. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020 Jul;26(7):1017–32.

VIII. Tabary M, Khanmohammadi S, Araghi F, Dadkhahfar S, Tavangar SM. Pathologic features of COVID-19: A concise review. Pathol Res Pract. 2020 Sep;216(9):153097.

IX. Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021 Mar;19(3):141–54.

X. CDC. El COVID-19 y su salud [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2021 Apr 30]. Available from: https://espanol.cdc.gov/coronavirus/2019- ncov/ need-extra-precautions/people-with-medical-conditions.html

XI. Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected — obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol. 2021 Mar;17(3):135–49.